Skip to main content
Erschienen in: Annals of Surgical Oncology 2/2016

01.02.2016 | Breast Oncology

Microcalcifications in 1657 Patients with Pure Ductal Carcinoma in Situ of the Breast: Correlation with Clinical, Histopathologic, Biologic Features, and Local Recurrence

verfasst von: Gaiane M. Rauch, MD, PhD, Brian P. Hobbs, PhD, Henry M. Kuerer, MD, PhD, Marion E. Scoggins, MD, Ana P. Benveniste, MD, Young Mi Park, MD, Abigail S. Caudle, MD, Patricia S. Fox, MS, Benjamin D. Smith, MD, Beatriz E. Adrada, MD, Savitri Krishnamurthy, MD, Wei T. Yang, MD

Erschienen in: Annals of Surgical Oncology | Ausgabe 2/2016

Einloggen, um Zugang zu erhalten

Abstract

Purpose

This study was designed to determine the relationship of microcalcification morphology and distribution with clinical, histopathologic, biologic features, and local recurrence (LR) in patients with pure ductal carcinoma in situ (DCIS) of the breast.

Methods

All patients with pure DCIS who underwent preoperative mammography at our institution from 1996 through 2009 were identified. Mammographic findings were classified according to the ACR BI-RADS lexicon. Associations between mammographic findings and clinical, histopathologic, biologic characteristics, and LR were analyzed. Statistical inference used multiple logistic regression and Cox proportional hazards regression adjusted for age and confounding due to bias from nonrandomized selection of radiation therapy.

Results

We identified 1657 patients with microcalcifications visualized on mammography. The mean age at diagnosis was 55 years (SD, 11). The mean follow-up was 7 years (range 1–16). Ipsilateral LR was 4 % in segmentectomy (987) and 1.5 % in mastectomy (670) patients. Increased LR risk was seen in patients with dense breast tissue (p < 0.05) and larger DCIS size (p < 0.01). Radiation therapy was associated with a 2.8-fold decrease in the LR risk. Fine linear (branching) microcalcifications were associated with 5.2-fold increase in LR. Extremely dense breast tissue was associated with positive/close margins (p = 0.04) and multicentricity (p < 0.01). Younger women were more likely to have extremely dense breast tissue (p < 0.0001), multicentric disease (p < 0.0004), and undergo mastectomy (p < 0.0001).

Conclusions

Dense breast tissue, large DCIS size, and fine linear (branching) microcalcifications were associated with increased LR, yet overall LR rates remained low. Extremely dense breast tissue was a risk factor for multicentricity and positive margins in DCIS.
Literatur
1.
Zurück zum Zitat Ernster VL, Ballard-Barbash R, Barlow WE, et al. Detection of ductal carcinoma in situ in women undergoing screening mammography. J Natl Cancer Inst. 2002;94(20):1546–54.PubMedCrossRef Ernster VL, Ballard-Barbash R, Barlow WE, et al. Detection of ductal carcinoma in situ in women undergoing screening mammography. J Natl Cancer Inst. 2002;94(20):1546–54.PubMedCrossRef
2.
Zurück zum Zitat Parker J, Dance DR, Davies DH, Yeoman LJ, Michell MJ, Humphreys S. Classification of ductal carcinoma in situ by image analysis of calcifications from digital mammograms. Br J Radiol. 1995;68(806):150–9.PubMedCrossRef Parker J, Dance DR, Davies DH, Yeoman LJ, Michell MJ, Humphreys S. Classification of ductal carcinoma in situ by image analysis of calcifications from digital mammograms. Br J Radiol. 1995;68(806):150–9.PubMedCrossRef
3.
Zurück zum Zitat Bijker N, Meijnen P, Peterse JL, et al. Breast-conserving treatment with or without radiotherapy in ductal carcinoma-in situ: ten-year results of European Organisation for Research and Treatment of Cancer randomized phase III trial 10853–a study by the EORTC Breast Cancer Cooperative Group and EORTC Radiotherapy Group. J Clin Oncol. 2006;24(21):3381–7.PubMedCrossRef Bijker N, Meijnen P, Peterse JL, et al. Breast-conserving treatment with or without radiotherapy in ductal carcinoma-in situ: ten-year results of European Organisation for Research and Treatment of Cancer randomized phase III trial 10853–a study by the EORTC Breast Cancer Cooperative Group and EORTC Radiotherapy Group. J Clin Oncol. 2006;24(21):3381–7.PubMedCrossRef
4.
Zurück zum Zitat Boyages J, Delaney G, Taylor R. Predictors of local recurrence after treatment of ductal carcinoma in situ: a meta-analysis. Cancer. 1999;85(3):616–28.PubMedCrossRef Boyages J, Delaney G, Taylor R. Predictors of local recurrence after treatment of ductal carcinoma in situ: a meta-analysis. Cancer. 1999;85(3):616–28.PubMedCrossRef
5.
Zurück zum Zitat Menell JH, Morris EA, Dershaw DD, Abramson AF, Brogi E, Liberman L. Determination of the presence and extent of pure ductal carcinoma in situ by mammography and magnetic resonance imaging. Breast J. 2005;11(6):382–90.PubMedCrossRef Menell JH, Morris EA, Dershaw DD, Abramson AF, Brogi E, Liberman L. Determination of the presence and extent of pure ductal carcinoma in situ by mammography and magnetic resonance imaging. Breast J. 2005;11(6):382–90.PubMedCrossRef
6.
Zurück zum Zitat Sue GR, Lannin DR, Killelea B, Chagpar AB. Predictors of microinvasion and its prognostic role in ductal carcinoma in situ. Am J Surg. 2013; 206: 478–81.PubMedCrossRef Sue GR, Lannin DR, Killelea B, Chagpar AB. Predictors of microinvasion and its prognostic role in ductal carcinoma in situ. Am J Surg. 2013; 206: 478–81.PubMedCrossRef
7.
Zurück zum Zitat Zunzunegui RG, Chung MA, Oruwari J, Golding D, Marchant DJ, Cady B. Casting-type calcifications with invasion and high-grade ductal carcinoma in situ: a more aggressive disease? Arch Surg. 2003;138(5):537–40.PubMedCrossRef Zunzunegui RG, Chung MA, Oruwari J, Golding D, Marchant DJ, Cady B. Casting-type calcifications with invasion and high-grade ductal carcinoma in situ: a more aggressive disease? Arch Surg. 2003;138(5):537–40.PubMedCrossRef
8.
Zurück zum Zitat Stomper PC, Geradts J, Edge SB, Levine EG. Mammographic predictors of the presence and size of invasive carcinomas associated with malignant microcalcification lesions without a mass. AJR Am J Roentgenol. 2003;181(6):1679–84.PubMedCrossRef Stomper PC, Geradts J, Edge SB, Levine EG. Mammographic predictors of the presence and size of invasive carcinomas associated with malignant microcalcification lesions without a mass. AJR Am J Roentgenol. 2003;181(6):1679–84.PubMedCrossRef
9.
Zurück zum Zitat Roses RE, Arun BK, Lari SA, et al. Ductal carcinoma-in situ of the breast with subsequent distant metastasis and death. Ann Surg Oncol. 2011;18(10):2873–8.PubMedCrossRef Roses RE, Arun BK, Lari SA, et al. Ductal carcinoma-in situ of the breast with subsequent distant metastasis and death. Ann Surg Oncol. 2011;18(10):2873–8.PubMedCrossRef
10.
Zurück zum Zitat Boughey JC, Gonzalez RJ, Bonner E, Kuerer HM. Current treatment and clinical trial developments for ductal carcinoma in situ of the breast. Oncologist. 2007;12(11):1276–87.PubMedCrossRef Boughey JC, Gonzalez RJ, Bonner E, Kuerer HM. Current treatment and clinical trial developments for ductal carcinoma in situ of the breast. Oncologist. 2007;12(11):1276–87.PubMedCrossRef
11.
Zurück zum Zitat MacDonald HR, Silverstein MJ, Mabry H, et al. Local control in ductal carcinoma in situ treated by excision alone: incremental benefit of larger margins. Am J Surg. 2005;190(4):521–5.PubMedCrossRef MacDonald HR, Silverstein MJ, Mabry H, et al. Local control in ductal carcinoma in situ treated by excision alone: incremental benefit of larger margins. Am J Surg. 2005;190(4):521–5.PubMedCrossRef
12.
Zurück zum Zitat Yi M, Krishnamurthy S, Kuerer HM, et al. Role of primary tumor characteristics in predicting positive sentinel lymph nodes in patients with ductal carcinoma in situ or microinvasive breast cancer. Am J Surg. 2008;196(1):81-7.PubMedPubMedCentralCrossRef Yi M, Krishnamurthy S, Kuerer HM, et al. Role of primary tumor characteristics in predicting positive sentinel lymph nodes in patients with ductal carcinoma in situ or microinvasive breast cancer. Am J Surg. 2008;196(1):81-7.PubMedPubMedCentralCrossRef
13.
Zurück zum Zitat Holland R, Hendriks JH. Microcalcifications associated with ductal carcinoma in situ: mammographic-pathologic correlation. Sem Diagn Pathol. 1994;11(3):181–92. Holland R, Hendriks JH. Microcalcifications associated with ductal carcinoma in situ: mammographic-pathologic correlation. Sem Diagn Pathol. 1994;11(3):181–92.
14.
Zurück zum Zitat Hofvind S, Iversen BF, Eriksen L, Styr BM, Kjellevold K, Kurz KD. Mammographic morphology and distribution of calcifications in ductal carcinoma in situ diagnosed in organized screening. Acta Radiol. 2011;52(5):481–7.PubMedCrossRef Hofvind S, Iversen BF, Eriksen L, Styr BM, Kjellevold K, Kurz KD. Mammographic morphology and distribution of calcifications in ductal carcinoma in situ diagnosed in organized screening. Acta Radiol. 2011;52(5):481–7.PubMedCrossRef
15.
Zurück zum Zitat Barreau B, de Mascarel I, Feuga C, et al. Mammography of ductal carcinoma in situ of the breast: review of 909 cases with radiographic-pathologic correlations. Eur J Radiol. 2005;54(1):55–61.PubMedCrossRef Barreau B, de Mascarel I, Feuga C, et al. Mammography of ductal carcinoma in situ of the breast: review of 909 cases with radiographic-pathologic correlations. Eur J Radiol. 2005;54(1):55–61.PubMedCrossRef
16.
Zurück zum Zitat Poplack SP, Wells WA. Ductal carcinoma in situ of the breast: mammographic-pathologic correlation. AJR Am J Roentgenol. 1998;170(6):1543–9.PubMedCrossRef Poplack SP, Wells WA. Ductal carcinoma in situ of the breast: mammographic-pathologic correlation. AJR Am J Roentgenol. 1998;170(6):1543–9.PubMedCrossRef
17.
Zurück zum Zitat Bai HX, Motwani SB, Higgins SA, et al. Breast conservation therapy for ductal carcinoma in situ (DCIS): does presentation of disease affect long-term outcomes? Int J Clin Oncol. 2013; 19:460–66PubMedCrossRef Bai HX, Motwani SB, Higgins SA, et al. Breast conservation therapy for ductal carcinoma in situ (DCIS): does presentation of disease affect long-term outcomes? Int J Clin Oncol. 2013; 19:460–66PubMedCrossRef
18.
Zurück zum Zitat Shaitelman SF, Wilkinson JB, Kestin LL, et al. Long-term outcome in patients with ductal carcinoma in situ treated with breast-conserving therapy: implications for optimal follow-up strategies. Int J Radiat Oncol Biol Phys. 2012;83(3):e305–12.PubMedCrossRef Shaitelman SF, Wilkinson JB, Kestin LL, et al. Long-term outcome in patients with ductal carcinoma in situ treated with breast-conserving therapy: implications for optimal follow-up strategies. Int J Radiat Oncol Biol Phys. 2012;83(3):e305–12.PubMedCrossRef
19.
Zurück zum Zitat Vargas C, Kestin L, Go N, et al. Factors associated with local recurrence and cause-specific survival in patients with ductal carcinoma in situ of the breast treated with breast-conserving therapy or mastectomy. Int J Radiat Oncol Biol Phys. 2005;63(5):1514–21.PubMedCrossRef Vargas C, Kestin L, Go N, et al. Factors associated with local recurrence and cause-specific survival in patients with ductal carcinoma in situ of the breast treated with breast-conserving therapy or mastectomy. Int J Radiat Oncol Biol Phys. 2005;63(5):1514–21.PubMedCrossRef
20.
Zurück zum Zitat Yi M, Meric-Bernstam F, Kuerer HM, et al. Evaluation of a breast cancer nomogram for predicting risk of ipsilateral breast tumor recurrences in patients with ductal carcinoma in situ after local excision. J Clin Oncol. 2012;30(6):600–7.PubMedPubMedCentralCrossRef Yi M, Meric-Bernstam F, Kuerer HM, et al. Evaluation of a breast cancer nomogram for predicting risk of ipsilateral breast tumor recurrences in patients with ductal carcinoma in situ after local excision. J Clin Oncol. 2012;30(6):600–7.PubMedPubMedCentralCrossRef
21.
Zurück zum Zitat Tse G, Tan PH, Pang AL, Tang AP, Cheung HS. Calcification in breast lesions: pathologists’ perspective. J Clin Pathol. 2008;61(2):145–51.PubMedCrossRef Tse G, Tan PH, Pang AL, Tang AP, Cheung HS. Calcification in breast lesions: pathologists’ perspective. J Clin Pathol. 2008;61(2):145–51.PubMedCrossRef
22.
Zurück zum Zitat Tabar L, Chen HH, Duffy SW, et al. A novel method for prediction of long-term outcome of women with T1a, T1b, and 10-14 mm invasive breast cancers: a prospective study. Lancet. 2000;355 (9202):429–33.PubMedCrossRef Tabar L, Chen HH, Duffy SW, et al. A novel method for prediction of long-term outcome of women with T1a, T1b, and 10-14 mm invasive breast cancers: a prospective study. Lancet. 2000;355 (9202):429–33.PubMedCrossRef
23.
Zurück zum Zitat Tabar L, Tony Chen HH, Amy Yen MF, et al. Mammographic tumor features can predict long-term outcomes reliably in women with 1-14-mm invasive breast carcinoma. Cancer. 2004;101(8):1745–59.PubMedCrossRef Tabar L, Tony Chen HH, Amy Yen MF, et al. Mammographic tumor features can predict long-term outcomes reliably in women with 1-14-mm invasive breast carcinoma. Cancer. 2004;101(8):1745–59.PubMedCrossRef
24.
Zurück zum Zitat Palka I, Ormandi K, Gaal S, Boda K, Kahan Z. Casting-type calcifications on the mammogram suggest a higher probability of early relapse and death among high-risk breast cancer patients. Acta Oncol. 2007;46(8):1178–83.PubMedCrossRef Palka I, Ormandi K, Gaal S, Boda K, Kahan Z. Casting-type calcifications on the mammogram suggest a higher probability of early relapse and death among high-risk breast cancer patients. Acta Oncol. 2007;46(8):1178–83.PubMedCrossRef
25.
Zurück zum Zitat Rauch GM, Kuerer HM, Scoggins ME, et al. Clinicopathologic, mammographic, and sonographic features in 1,187 patients with pure ductal carcinoma in situ of the breast by estrogen receptor status. Breast Cancer Res Treat. 2013;139(3):639–47.PubMedPubMedCentralCrossRef Rauch GM, Kuerer HM, Scoggins ME, et al. Clinicopathologic, mammographic, and sonographic features in 1,187 patients with pure ductal carcinoma in situ of the breast by estrogen receptor status. Breast Cancer Res Treat. 2013;139(3):639–47.PubMedPubMedCentralCrossRef
26.
Zurück zum Zitat D’Orsi C, Mendelson E, Ikeda D. Breast imaging reporting and data system: ACR BI-RADS—Breast Imaging Atlas. Reston, VA: American College of Radiology; 2003. D’Orsi C, Mendelson E, Ikeda D. Breast imaging reporting and data system: ACR BI-RADS—Breast Imaging Atlas. Reston, VA: American College of Radiology; 2003.
27.
Zurück zum Zitat Fine JP, Gray RJ. A proportional hazards model for the subdistribution of a competing risk. J Am Stat Assoc. 1999;94(446):496–509.CrossRef Fine JP, Gray RJ. A proportional hazards model for the subdistribution of a competing risk. J Am Stat Assoc. 1999;94(446):496–509.CrossRef
28.
Zurück zum Zitat Austin PC. An introduction to propensity score methods for reducing the effects of confounding in observational studies. Multivar Behav Res. 2011;46(3):399–424.CrossRef Austin PC. An introduction to propensity score methods for reducing the effects of confounding in observational studies. Multivar Behav Res. 2011;46(3):399–424.CrossRef
29.
Zurück zum Zitat Stomper PC, Connolly J. Ductal carcinoma in situ of the breast: correlation between mammographic calcification and tumor subtype. AJR Am J Roentgenol. 1992;159(3):483–85.PubMedCrossRef Stomper PC, Connolly J. Ductal carcinoma in situ of the breast: correlation between mammographic calcification and tumor subtype. AJR Am J Roentgenol. 1992;159(3):483–85.PubMedCrossRef
30.
Zurück zum Zitat Evans AJ, Pinder S, Ellis IO, et al. Screening-detected and symptomatic ductal carcinoma in situ: mammographic features with pathologic correlation. Radiology. 1994;191(1):237–40.PubMedCrossRef Evans AJ, Pinder S, Ellis IO, et al. Screening-detected and symptomatic ductal carcinoma in situ: mammographic features with pathologic correlation. Radiology. 1994;191(1):237–40.PubMedCrossRef
31.
Zurück zum Zitat Thomson JZ, Evans AJ, Pinder SE, Burrell HC, Wilson AR, Ellis IO. Growth pattern of ductal carcinoma in situ (DCIS): a retrospective analysis based on mammographic findings. Br J Cancer. 2001;85(2):225–7.PubMedPubMedCentralCrossRef Thomson JZ, Evans AJ, Pinder SE, Burrell HC, Wilson AR, Ellis IO. Growth pattern of ductal carcinoma in situ (DCIS): a retrospective analysis based on mammographic findings. Br J Cancer. 2001;85(2):225–7.PubMedPubMedCentralCrossRef
32.
Zurück zum Zitat Tabár L, Tot T, Dean PB. Casting type calcifications: sign of a subtype with deceptive features. Thieme; 2007. Tabár L, Tot T, Dean PB. Casting type calcifications: sign of a subtype with deceptive features. Thieme; 2007.
33.
Zurück zum Zitat Stomper PC, Margolin FR. Ductal carcinoma in situ: the mammographer’s perspective. AJR Am J Roentgenol. 1994;162(3):585–91.PubMedCrossRef Stomper PC, Margolin FR. Ductal carcinoma in situ: the mammographer’s perspective. AJR Am J Roentgenol. 1994;162(3):585–91.PubMedCrossRef
34.
Zurück zum Zitat Alvarado R, Lari SA, Roses RE, et al. Biology, treatment, and outcome in very young and older women with DCIS. Ann Surg Oncol. 2012;19(12):3777–84.PubMedCrossRef Alvarado R, Lari SA, Roses RE, et al. Biology, treatment, and outcome in very young and older women with DCIS. Ann Surg Oncol. 2012;19(12):3777–84.PubMedCrossRef
35.
Zurück zum Zitat Ho A, Goenka A, Ishill N, et al. The effect of age in the outcome and treatment of older women with ductal carcinoma in situ. Breast. 2011;20(1):71–7.PubMedCrossRef Ho A, Goenka A, Ishill N, et al. The effect of age in the outcome and treatment of older women with ductal carcinoma in situ. Breast. 2011;20(1):71–7.PubMedCrossRef
36.
Zurück zum Zitat Fitzsullivan E, Lari SA, Smith B, et al. Incidence and consequence of close margins in patients with ductal carcinoma-in situ treated with mastectomy: is further therapy warranted? Ann Surg Oncol. 2013;20(13):4103–12.PubMedPubMedCentralCrossRef Fitzsullivan E, Lari SA, Smith B, et al. Incidence and consequence of close margins in patients with ductal carcinoma-in situ treated with mastectomy: is further therapy warranted? Ann Surg Oncol. 2013;20(13):4103–12.PubMedPubMedCentralCrossRef
37.
Zurück zum Zitat Biglia N, Bounous VE, Martincich L, et al. Role of MRI (magnetic resonance imaging) versus conventional imaging for breast cancer presurgical staging in young women or with dense breast. Eur J Surg Oncol. 2011;37(3):199–204.PubMedCrossRef Biglia N, Bounous VE, Martincich L, et al. Role of MRI (magnetic resonance imaging) versus conventional imaging for breast cancer presurgical staging in young women or with dense breast. Eur J Surg Oncol. 2011;37(3):199–204.PubMedCrossRef
38.
Zurück zum Zitat Kuhl CK, Schrading S, Bieling HB, et al. MRI for diagnosis of pure ductal carcinoma in situ: a prospective observational study. Lancet. 2007;370(9586):485–92.PubMedCrossRef Kuhl CK, Schrading S, Bieling HB, et al. MRI for diagnosis of pure ductal carcinoma in situ: a prospective observational study. Lancet. 2007;370(9586):485–92.PubMedCrossRef
39.
Zurück zum Zitat Lehman CD. Magnetic resonance imaging in the evaluation of ductal carcinoma in situ. J Natl Cancer Inst Monogr. 2010;2010(41):150–1.PubMedCrossRef Lehman CD. Magnetic resonance imaging in the evaluation of ductal carcinoma in situ. J Natl Cancer Inst Monogr. 2010;2010(41):150–1.PubMedCrossRef
40.
Zurück zum Zitat Kuerer HM, Albarracin CT, Yang WT, et al. Ductal carcinoma in situ: state of the science and roadmap to advance the field. J Clin Oncol. 2009;27(2):279–88.PubMedCrossRef Kuerer HM, Albarracin CT, Yang WT, et al. Ductal carcinoma in situ: state of the science and roadmap to advance the field. J Clin Oncol. 2009;27(2):279–88.PubMedCrossRef
42.
Zurück zum Zitat Allegra CJ, Aberle DR, Ganschow P, et al. National Institutes of Health State-of-the-Science Conference statement: diagnosis and management of ductal carcinoma in situ, September 22-24, 2009. J Natl Cancer Inst. 2010;102(3):161–9.PubMedCrossRef Allegra CJ, Aberle DR, Ganschow P, et al. National Institutes of Health State-of-the-Science Conference statement: diagnosis and management of ductal carcinoma in situ, September 22-24, 2009. J Natl Cancer Inst. 2010;102(3):161–9.PubMedCrossRef
43.
Zurück zum Zitat Rudloff U, Jacks LM, Goldberg JI, et al. Nomogram for predicting the risk of local recurrence after breast-conserving surgery for ductal carcinoma in situ. J Clin Oncol. 2010;28(23):3762–9.PubMedCrossRef Rudloff U, Jacks LM, Goldberg JI, et al. Nomogram for predicting the risk of local recurrence after breast-conserving surgery for ductal carcinoma in situ. J Clin Oncol. 2010;28(23):3762–9.PubMedCrossRef
44.
Zurück zum Zitat Wang F, Li H, Tan PH, et al. Validation of a nomogram in the prediction of local recurrence risks after conserving surgery for Asian women with ductal carcinoma in situ of the breast. Clin Oncol. 2014; 26: 684–91.CrossRef Wang F, Li H, Tan PH, et al. Validation of a nomogram in the prediction of local recurrence risks after conserving surgery for Asian women with ductal carcinoma in situ of the breast. Clin Oncol. 2014; 26: 684–91.CrossRef
45.
Zurück zum Zitat Pinsky RW, Rebner M, Pierce LJ, et al. Recurrent cancer after breast-conserving surgery with radiation therapy for ductal carcinoma in situ: mammographic features, method of detection, and stage of recurrence. AJR Am J Roentgenol. 2007;189(1):140–4.PubMedCrossRef Pinsky RW, Rebner M, Pierce LJ, et al. Recurrent cancer after breast-conserving surgery with radiation therapy for ductal carcinoma in situ: mammographic features, method of detection, and stage of recurrence. AJR Am J Roentgenol. 2007;189(1):140–4.PubMedCrossRef
46.
Zurück zum Zitat Rakovitch E, Pignol JP, Hanna W, et al. Significance of multifocality in ductal carcinoma in situ: outcomes of women treated with breast-conserving therapy. J Clin Oncol. 2007;25(35):5591–6.PubMedCrossRef Rakovitch E, Pignol JP, Hanna W, et al. Significance of multifocality in ductal carcinoma in situ: outcomes of women treated with breast-conserving therapy. J Clin Oncol. 2007;25(35):5591–6.PubMedCrossRef
47.
Zurück zum Zitat Yerushalmi R, Tyldesley S, Woods R, Kennecke HF, Speers C, Gelmon KA. Is breast-conserving therapy a safe option for patients with tumor multicentricity and multifocality? Ann Oncol. 2011;23(4):876–81.PubMedCrossRef Yerushalmi R, Tyldesley S, Woods R, Kennecke HF, Speers C, Gelmon KA. Is breast-conserving therapy a safe option for patients with tumor multicentricity and multifocality? Ann Oncol. 2011;23(4):876–81.PubMedCrossRef
48.
Zurück zum Zitat Holmberg L, Wong YN, Tabar L, et al. Mammography casting-type calcification and risk of local recurrence in DCIS: analyses from a randomised study. Br J Cancer. 2013;108(4):812–9.PubMedPubMedCentralCrossRef Holmberg L, Wong YN, Tabar L, et al. Mammography casting-type calcification and risk of local recurrence in DCIS: analyses from a randomised study. Br J Cancer. 2013;108(4):812–9.PubMedPubMedCentralCrossRef
49.
Zurück zum Zitat Kuerer HM. Ductal carcinoma in situ: treatment or active surveillance? Expert Rev Anticancer Ther. 2015;15(7):777–85.PubMedCrossRef Kuerer HM. Ductal carcinoma in situ: treatment or active surveillance? Expert Rev Anticancer Ther. 2015;15(7):777–85.PubMedCrossRef
Metadaten
Titel
Microcalcifications in 1657 Patients with Pure Ductal Carcinoma in Situ of the Breast: Correlation with Clinical, Histopathologic, Biologic Features, and Local Recurrence
verfasst von
Gaiane M. Rauch, MD, PhD
Brian P. Hobbs, PhD
Henry M. Kuerer, MD, PhD
Marion E. Scoggins, MD
Ana P. Benveniste, MD
Young Mi Park, MD
Abigail S. Caudle, MD
Patricia S. Fox, MS
Benjamin D. Smith, MD
Beatriz E. Adrada, MD
Savitri Krishnamurthy, MD
Wei T. Yang, MD
Publikationsdatum
01.02.2016
Verlag
Springer US
Erschienen in
Annals of Surgical Oncology / Ausgabe 2/2016
Print ISSN: 1068-9265
Elektronische ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-015-4876-6

Weitere Artikel der Ausgabe 2/2016

Annals of Surgical Oncology 2/2016 Zur Ausgabe

Mehr Frauen im OP – weniger postoperative Komplikationen

21.05.2024 Allgemeine Chirurgie Nachrichten

Ein Frauenanteil von mindestens einem Drittel im ärztlichen Op.-Team war in einer großen retrospektiven Studie aus Kanada mit einer signifikanten Reduktion der postoperativen Morbidität assoziiert.

„Übersichtlicher Wegweiser“: Lauterbachs umstrittener Klinik-Atlas ist online

17.05.2024 Klinik aktuell Nachrichten

Sie sei „ethisch geboten“, meint Gesundheitsminister Karl Lauterbach: mehr Transparenz über die Qualität von Klinikbehandlungen. Um sie abzubilden, lässt er gegen den Widerstand vieler Länder einen virtuellen Klinik-Atlas freischalten.

Was nützt die Kraniektomie bei schwerer tiefer Hirnblutung?

17.05.2024 Hirnblutung Nachrichten

Eine Studie zum Nutzen der druckentlastenden Kraniektomie nach schwerer tiefer supratentorieller Hirnblutung deutet einen Nutzen der Operation an. Für überlebende Patienten ist das dennoch nur eine bedingt gute Nachricht.

Klinikreform soll zehntausende Menschenleben retten

15.05.2024 Klinik aktuell Nachrichten

Gesundheitsminister Lauterbach hat die vom Bundeskabinett beschlossene Klinikreform verteidigt. Kritik an den Plänen kommt vom Marburger Bund. Und in den Ländern wird über den Gang zum Vermittlungsausschuss spekuliert.

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.